Cargando…

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences

RATIONALE & OBJECTIVE: We sought to elicit patient preferences regarding the use of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and its tradeoffs of risk of kidney failure and risk of serious infection. STUDY DESIGN: Patient survey. SETTING & PARTICIPAN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collister, David, Farrar, Mark, Farrar, Lesha, Brown, Paul, Booth, Michelle, Firth, Tracy, Mahr, Alfred, Zeng, Linan, Little, Mark A., Mustafa, Reem A., Fussner, Lynn A., Meara, Alexa, Guyatt, Gordon, Jayne, David, Merkel, Peter A., Walsh, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851885/ https://www.ncbi.nlm.nih.gov/pubmed/36686273 http://dx.doi.org/10.1016/j.xkme.2022.100595

Ejemplares similares

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic review
por: Xiao, Yingqi, et al.
Publicado: (2022)

ANCA Associated Vasculitis Subtypes: Response [Letter]
por: Merkel, Peter A, et al.
Publicado: (2022)

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
por: Yates, Max, et al.
Publicado: (2017)

Challenges of defining renal response in ANCA-associated vasculitis: call to action?
por: Odler, Balazs, et al.
Publicado: (2023)

In vivo approaches to investigate ANCA-associated vasculitis: lessons and limitations
por: Heeringa, Peter, et al.
Publicado: (2011)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Risk factors for serious infections in ANCA-associated vasculitis
por: Odler, Balazs, et al.
Publicado: (2023)

The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum
por: Kronbichler, Andreas, et al.
Publicado: (2021)

Vitamin D status in ANCA-associated vasculitis
por: Doubelt, Irena, et al.
Publicado: (2023)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
por: Thompson, Gwen E., et al.
Publicado: (2020)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Investigation of type I interferon responses in ANCA-associated vasculitis
por: Batten, Isabella, et al.
Publicado: (2021)

ANCA-associated vasculitis in Ireland: a multi-centre national cohort study
por: Scott, Jennifer, et al.
Publicado: (2022)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
por: Robson, Joanna C, et al.
Publicado: (2018)

Circulating Angiopoietin-2 as a Biomarker in ANCA-Associated Vasculitis
por: Monach, Paul A., et al.
Publicado: (2012)

High risk of stroke in ANCA-associated vasculitis—a population-based study
por: Tabakovic, Dennis, et al.
Publicado: (2022)

Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020)

Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies
por: O’Brien, Eóin C., et al.
Publicado: (2015)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Plasma Exchange in ANCA-Associated Vasculitis: A Narrative Review
por: Tsiakas, Stathis, et al.
Publicado: (2021)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis
por: Rathmann, Jens, et al.
Publicado: (2022)

Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study
por: Coattrenec, Yann, et al.
Publicado: (2021)

Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
por: McClure, Mark E, et al.
Publicado: (2020)

ANCA Vasculitis Induction Management During the COVID-19 Pandemic
por: Salas, Antonio, et al.
Publicado: (2021)

Ocular disease in patients with ANCA-positive vasculitis
por: Watkins, Angela S., et al.
Publicado: (2009)

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab
por: Bruchfeld, Annette, et al.
Publicado: (2021)

ANCA-associated vasculitis in childhood: recent advances
por: Calatroni, Marta, et al.
Publicado: (2017)

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020)

Utility of interval kidney biopsy in ANCA-associated vasculitis
por: Chapman, Gavin B, et al.
Publicado: (2021)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Mechanisms of thrombosis in ANCA-associated vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021)

Complement Inhibition in ANCA-Associated Vasculitis
por: Tesar, Vladimir, et al.
Publicado: (2022)

The involvement of NETs in ANCA-associated vasculitis
por: Shiratori-Aso, Satoka, et al.
Publicado: (2023)

Diagnosing ANCA-associated vasculitis in ANCA positive patients: A retrospective analysis on the role of clinical symptoms and the ANCA titre
por: Houben, Eline, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4525qlu52a8ibp8akmo1733r9v